• 1
    Hacke W, Kaste M, Fieschi C et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998;17:124551.
  • 2
    Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:131729.
  • 3
    Singer OC, Hamann GF, Misselwitz B, Steinmetz H, Foerch C. Arbeitsgruppe Schlaganfall Hessen: time trends in systemic thrombolysis in a large hospital-based stroke registry. Cerebrovasc Dis 2012;33:31621.
  • 4
    Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008;371:161223.
  • 5
    Thomalla G, Rossbach P, Rosenkranz M et al. Negative fluid-attenuated inversion recovery imaging identifies acute ischemic stroke at 3 hours or less. Ann Neurol 2009;65:72432.
  • 6
    Thomalla G, Cheng B, Ebinger M et al. DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4.5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol 2011;10:97886.
  • 7
    Emeriau S, Serre I, Toubas O, Pombourcq F, Oppenheim C, Pierot L. Can diffusion-weighted imaging-fluid-attenuated inversion recovery mismatch (positive diffusion-weighted imaging/negative fluid-attenuated inversion recovery) at 3 tesla identify patients with stroke at 3 Tesla identify patients with stroke at <4.5 hours? Stroke 2013;44:164751.
  • 8
    Petkova M, Rodrigo S, Lamy C et al. MR imaging helps predict time from symptom onset in patients with acute stroke: implications for patients with unknown onset time. Radiology 2010;257:78292.
  • 9
    Aoki J, Kimura K, Iguchi Y et al. Intravenous thrombolysis based on diffusion-weighted imaging and fluid-attenuated inversion recovery mismatch in acute stroke patients with unknown onset time. Cerebrovasc Dis 2011;31:43541.
  • 10
    Cho AH, Sohn SI, Han MK et al. Safety and efficacy of MRI-based thrombolysis in unclear-onset stroke. A preliminary report. Cerebrovasc Dis 2008;25:5729.
  • 11
    Schellinger PD, Fiebach JB, Hacke W. Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status. Stroke 2003;34:57583.
  • 12
    Kucinski T, Vaterlein O, Glauche V et al. Correlation of apparent diffusion coefficient and computed tomography density in acute ischemic stroke. Stroke 2002;33:178691.
  • 13
    Singer OC, Humpich MC, Fiehler J et al. Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging. Ann Neurol 2008;63:5260.
  • 14
    Adams HP, Bendixen BH, Kapelle LJ et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:3541.
  • 15
    Aoki J, Kimura K, Iguchi Y, Shibazaki K, Sakai K, Iwanaga T. FLAIR can estimate the onset time in acute ischemic stroke patients. J Neurol Sci 2010;293:3944.
  • 16
    Ebinger M, Ostwaldt AC, Galinovic I et al. Clinical and radiological courses do not differ between fluid-attenuated inversion recovery-positive and negative patients with stroke after thrombolysis. Stroke 2010;41:18235.
  • 17
    Cho AH, Kim JS, Kim SJ et al. Focal fluid-attenuated inversion recovery hyperintensity within acute diffusion-weighted imaging lesions is associated with symptomatic intracerebral hemorrhage after thrombolysis. Stroke 2008;39:34246.
  • 18
    Campbell BC, Costello C, Christensen S et al. Fluid-attenuated inversion recovery hyperintensity in acute ischemic stroke may not predict hemorrhagic transformation. Cerebrovasc Dis 2011;32:4015.
  • 19
    Dorado L, Millán M, Pérez de la Ossa N et al. Time to recanalization and risk of symptomatic intracerebral haemorrhage in patients treated with intravenous thrombolysis. Eur J Neurol 2012;19:12515.
  • 20
    Kimura K, Iguchi Y, Shibazaki K, Aoki J, Terasawa Y. Hemorrhagic transformation of ischemic brain tissue after t-PA thrombolysis as detected by MRI may be asymptomatic, but impair neurological recovery. J Neurol Sci 2008;272:13642.
  • 21
    Molina CA, Alvarez-Sabín J, Montaner J et al. Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke 2002;33:15516.
  • 22
    Thomalla G, Schwark C, Sobesky J et al. Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials. Stroke 2006;37:8528.
  • 23
    Campbell BC, Purushotham A, Christensen S et al. The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent. J Cereb Blood Flow Metab 2012;32:506.
  • 24
    von Kummer R, Allen KL, Holle R. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 1997;205:32733.
  • 25
    Hohenhaus M, Schmidt WU, Brunecker P. FLAIR vascular hyperintensities in acute ICA and MCA infarction: a marker for mismatch and stroke severity? Cerebrovasc Dis 2012;34:639.
  • 26
    Nighoghossian N, Hermier M, Berthezène Y et al. Early diagnosis of hemorrhagic transformation: diffusion/perfusion-weighted MRI versus CT scan. Cerebrovasc Dis 2001;11:1516.